Literature DB >> 27245501

Prostate cancer: Interfering with abiraterone metabolism to optimize therapy.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27245501     DOI： 10.1038/nrurol.2016.101

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.

Authors:  Zhenfei Li; Mohammad Alyamani; Jianneng Li; Kevin Rogacki; Mohamed Abazeed; Sunil K Upadhyay; Steven P Balk; Mary-Ellen Taplin; Richard J Auchus; Nima Sharifi
Journal:  Nature       Date:  2016-05-26       Impact factor: 49.962
  1 in total
  1 in total

1.  rAAV-delivered PTEN therapeutics for prostate cancer.

Authors:  Jianzhong Ai; Jia Li; Qin Su; Hong Ma; Qiang Wei; Hong Li; Guangping Gao
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 10.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.